tiprankstipranks
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
ABUS
Arbutus Biopharma
RESEARCH TOOLSreports

Arbutus Biopharma (ABUS) Revenue

Compare
1,272 Followers
StatisticsMarket CapRevenue

Arbutus Biopharma Revenue

Arbutus Biopharma had a revenue of 1.05M in the quarter ending Dec 31, 2025, with 98.68%. This bring the company's revenue in the last twelve months to 14.08M, Increased -3.58%. In the fiscal year ending Dec 31, 2025, Arbutus Biopharma had annual revenue of 14.08M with 128.21% growth.
Revenue (ttm)
14.08M
Revenue Growth
116.64%
P/S Ratio
59.55
Revenue/Employee
$320,068
Employees
44
Market Cap
$838.60M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
14.08M7.91M+128.21%
Dec 31, 2024
6.17M-11.97M-65.98%
Dec 31, 2023
18.14M-20.88M-53.51%
Dec 31, 2022
39.02M28.03M+255.11%
Dec 31, 2021
10.99M4.07M+58.92%
Dec 31, 2020
6.91M903.00K+15.02%
Dec 31, 2019
6.01M111.00K+1.88%
Dec 31, 2018
5.90M-4.80M-44.86%
Dec 31, 2017
10.70M――